IL18 and COVID-19: A key example is COVID-19, where NLRP3 inflammasome activation by SARS-CoV-2 results in massive release of IL-1β and IL-18, leading to cytokine release syndrome, with hyperactivation of myeloid cells and Th17 responses or IL-18-driven IFNγ production and Th1 responses.